Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LV Remodeling, Hypertrophy”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableEnrolling By InvitationNCT06763549
What this trial is testing

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

Who this might be right for
Cardiopulmonary FailureMyocardial Infarction (MI)Heart Decompensation+38 more
Peerbridge Health, Inc 15,000
Not applicableStudy completedNCT00976625
What this trial is testing

Diastolic Dysfunction in Aortic Regurgitation

Who this might be right for
Aortic Regurgitation
University of Bern 26
Post-approval studies (Phase 4)Ended earlyNCT01275339
What this trial is testing

Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot Study

Who this might be right for
Aortic StenosisLV Remodeling, Hypertrophy
Washington University School of Medicine 10
Not applicableStudy completedNCT02395107
What this trial is testing

Left Atrial Volume Index in Asymptomatic Aortic Stenosis

Who this might be right for
Aortic Valve StenosisHeart Failure
Odense University Hospital 100
Not applicableLooking for participantsNCT06699056
What this trial is testing

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

Who this might be right for
Ventricular Ejection FractionLVFLV Dysfunction+12 more
Peerbridge Health, Inc 1,500
Post-approval studies (Phase 4)Study completedNCT01176032
What this trial is testing

ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling

Who this might be right for
HypertensionLeft Ventricle Hypertrophy
Novartis Pharmaceuticals 74